Showing results (1191-1200 of 2,297) with videos related to
Sort By:
Pageof 230
Clinical and Experimental Medicine|February 25, 2009
Immunomodulation in the treatment of haematological malignanciesMichela Cesco-Gaspere, Emma Morris, Hans J StaussClinical and Experimental Medicine|September 30, 2008
The detection of sLFA-3 in plasma of patients with hemorrhagic fever with renal syndromeMing Xie, Ping Chen, Lin-Jing He, et al.Clinical and Experimental Medicine|September 30, 2008
The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patientsJeng-Ting Tsao, Chia-Chen Kuo, Shih-Chang LinClinical and Experimental Medicine|October 1, 2008
Darbepoetin in the control of cancer-related anaemiaFabrizio Franchi, Carlo Pastore, Giuseppe Nigita, et al.Clinical and Experimental Medicine|February 9, 2022
Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopeniaChewei Ou, Hung Chang, Yu-Shin Hung, et al.Clinical and Experimental Medicine|February 4, 2022
Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patientsAsmaa M Elbrolosy, Naglaa S Elabd, Gamalat A ElGedawy, et al.Clinical and Experimental Medicine|June 14, 2019
Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancerXiaofen Zhang, Shaoqing Ju, Xudong Wang, et al.Clinical and Experimental Medicine|June 9, 2019
Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case-control studyRachele Ciccocioppo, Sara Bozzini, Elena Betti, et al.Clinical and Experimental Medicine|October 11, 2019
IL-8 gene locus is associated with risk, severity and 28-day mortality of sepsis in a Chinese populationPeng Fu, Shouxiang Xie, Xiangcheng ZhangClinical and Experimental Medicine|May 22, 2019
Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapyRuyu Liu, Jiang Guo, Yao Lu, et al.Pageof 230